Maria Grazia Franzosi - Researcher Profile

Publications

3 shown

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial

Lars Wallentin , Salim Yusuf , Michael D. Ezekowitz +11 more

2010 The Lancet 1003 citations

Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation

John W. Eikelboom , Lars Wallentin , Stuart J. Connolly +13 more

Background— Dabigatran 150 and 110 mg twice a day and warfarin are effective for stroke prevention in atrial fibrillation. The purpose of this study was to compare their risks o...

2011 Circulation 1071 citations

Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study

Salim Yusuf , Steven Hawken , Stephanie Ôunpuu +12 more

2005 The Lancet 2861 citations

Frequent Co-Authors

Researcher Info

h-index: 3
Publications: 3
Citations: 4,935
Institution: Mario Negri Institute for Pharmacological Research

External Links

Google Scholar

Impact Metrics

h-index 3

h-index: Number of publications with at least h citations each.